Semaglutide, a Frontline Drug in Managing Type 2 Diabetes

Clinical Diabetology is a bimonthly, open access journal of scientific and educational profile, which was created by combining the scientific assumptions of Experimental and Clinical Diabetology (Diabetologia Doświadczalna i Kliniczna)

Authors

Institutions

Publication Details

Journal
Clinical Diabetology
Published
2025-12-31
DOI
https://doi.org/10.5603/cd.109919
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Semaglutide, a Frontline Drug in Managing Type 2 Diabetes

Vinod K. Abichandani
Clinical Diabetology
Diabetes Treatment and Management
article

Semaglutide, a Frontline Drug in Managing Type 2 Diabetes

Vinod K. Abichandani
article en

Abstract

Clinical Diabetology is a bimonthly, open access journal of scientific and educational profile, which was created by combining the scientific assumptions of Experimental and Clinical Diabetology (Diabetologia Doświadczalna i Kliniczna)

Clinical DiabetologyVol. 14(6)
Ahmedabad Civil Hospital (IN)
Good health and well-being
Openalex Percentile: Top 28%
Diabetes Treatment and Management
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Semaglutide, a Frontline Drug in Managing Type 2 Diabetes — Vinod K. Abichandani · Clinical Diabetology (2025) | TGRS Research Map | TGRS